Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Arcus Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of RCUS: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	131	1	142	+12
Shares	48.3M	17.0K	50.8M	+2.57M (+5.3%)
Value	$1.68B	$593.0K	$2.06B	+$373.8M (+22.2%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Arcus Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RCUS in Q4 2021
Institution	Shares	Value	% of portfolio
Healthcare of Ontario Pension Plan Trust Fund	370,597	$15.0M	0.03%
AXA S.A.	134,515	$5.44M	0.01%
Voloridge Investment Management, LLC	94,938	$3.84M	0.02%
EAM Investors, LLC	76,163	$3.08M	0.51%
Toronto Dominion Bank	56,013	$2.27M	0.00%
SEI Investments Co	50,159	$2.03M	0.00%
EAM Global Investors LLC	49,498	$2.00M	0.36%
Allspring Global Investments Holdings, LLC	20,250	$819.0K	0.00%
Squarepoint Ops LLC	17,415	$705.0K	0.00%
Natixis	15,100	$611.0K	0.00%
Verition Fund Management LLC	11,455	$464.0K	0.01%
Caxton Associates LP	11,387	$461.0K	0.06%
Ensign Peak Advisors, Inc	9,880	$400.0K	0.00%
Wexford Capital LP	9,800	$397.0K	0.04%
Jump Financial, LLC	9,783	$396.0K	0.02%
Janus Henderson Group PLC	7,981	$323.0K	0.00%
Royal Bank of Canada	7,515	$305.0K	0.00%
Winton Group Ltd	6,910	$280.0K	0.02%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	6,396	$259.0K	0.01%
Gsa Capital Partners LLP	6,210	$251.0K	0.03%
Quantamental Technologies LLC	5,793	$234.0K	0.12%
PDT Partners, LLC	5,051	$204.0K	0.02%
TriaGen Wealth Management LLC	5,000	$202.0K	0.10%
C M Bidwell & Associates Ltd	3,015	$122.0K	0.07%
Point72 Hong Kong Ltd	449	$18.0K	0.00%
Dark Forest Capital Management LP	149	$6.00K	0.00%
National Bank of Canada	100	$4.00K	0.00%
Signaturefd, LLC	26	$1.00K	0.00%
Covestor Ltd	17	$1.00K	0.00%
CWM, LLC	10	$0	0.00%
JFS Wealth Advisors, LLC	2	$0	0.00%
Schubert & Co	3	$0	0.00%

Sold out (20)

Institutions that held Arcus Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of RCUS in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Ameriprise Financial Inc	298,410	$10.4M
HealthCor Management, L.P.	70,050	$2.44M
Alpha Paradigm Partners, LLC	53,910	$1.88M
M&G Investment Management Ltd	41,631	$1.46M
Tudor Investment Corp Et Al	41,200	$1.44M
Sante Capital Fund, LP	24,139	$842.0K
Jane Street Group, LLC	22,515	$786.0K
White Pine Investment CO	18,939	$660.0K
STRS Ohio	16,400	$571.0K
Simplex Trading, LLC	20,237	$557.0K
Martingale Asset Management L P	15,800	$551.0K
Blueshift Asset Management, LLC	11,816	$412.0K
Vontobel Holding Ltd.	10,000	$349.0K
Ergoteles LLC	6,600	$230.0K
AQR Capital Management LLC	5,869	$205.0K
Bank Julius Baer & Co. Ltd, Zurich	4,000	$139.0K
Quantbot Technologies LP	2,000	$69.0K
Tarbox Family Office, Inc.	1,000	$35.0K
Group One Trading, L.P.	228	$8.00K
Bell Investment Advisors, Inc	18	$1.00K

Not filed for Q4 2021 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Copernicus Capital Management, LLC	17,000	$593.0K